|
Volumn 2, Issue 10, 2001, Pages 900-901
|
Redirecting T cell specificity by TCR gene transfer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HLA A2 ANTIGEN;
MURINE DOUBLE MINUTE ONCOPROTEIN 2;
ONCOPROTEIN;
T LYMPHOCYTE RECEPTOR ALPHA CHAIN;
T LYMPHOCYTE RECEPTOR BETA CHAIN;
UNCLASSIFIED DRUG;
VIRUS VECTOR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIGEN SPECIFICITY;
ARTICLE;
CELL SPECIFICITY;
CYTOMEGALOVIRUS INFECTION;
CYTOTOXIC LYMPHOCYTE;
DRUG DELIVERY SYSTEM;
GENE TARGETING;
GENE TRANSFER;
GENETIC TRANSDUCTION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
IMMUNOGLOBULIN GENE;
INFLUENZA;
MOLECULAR CLONING;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
RETROVIRUS;
T LYMPHOCYTE RECEPTOR GENE;
TUMOR;
TUMOR IMMUNOLOGY;
ANIMALS;
GENE THERAPY;
GENES, T-CELL RECEPTOR;
GENETIC VECTORS;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
MICE;
MODELS, IMMUNOLOGICAL;
NEOPLASMS;
NUCLEAR PROTEINS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-MDM2;
RETROVIRIDAE;
T-LYMPHOCYTES, CYTOTOXIC;
TRANSDUCTION, GENETIC;
VIRUS DISEASES;
|
EID: 0034778974
PISSN: 15292908
EISSN: None
Source Type: Journal
DOI: 10.1038/ni1001-900 Document Type: Article |
Times cited : (6)
|
References (8)
|